rabeprazole sodium

Generic: rabeprazole sodium

Labeler: advagen pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rabeprazole sodium
Generic Name rabeprazole sodium
Labeler advagen pharma limited
Dosage Form TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients

rabeprazole sodium 20 mg/1

Manufacturer
Advagen Pharma Limited

Identifiers & Regulatory

Product NDC 72888-059
Product ID 72888-059_4844a51a-513a-8b72-e063-6294a90ab996
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204237
Listing Expiration 2027-12-31
Marketing Start 2017-06-01

Pharmacologic Class

Classes
proton pump inhibitor [epc] proton pump inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72888059
Hyphenated Format 72888-059

Supplemental Identifiers

RxCUI
854868
UPC
0372888059907 0372888059303
UNII
3L36P16U4R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rabeprazole sodium (source: ndc)
Generic Name rabeprazole sodium (source: ndc)
Application Number ANDA204237 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 30 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-059-30)
  • 90 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-059-90)
source: ndc

Packages (2)

72888-059-30 30 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-059-30) 72888-059-90 90 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-059-90)

Ingredients (1)

rabeprazole sodium (20 mg/1)

Linked Drug Pages (1)

RABEPRAZOLE SODIUM ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4844a51a-513a-8b72-e063-6294a90ab996", "openfda": {"upc": ["0372888059907", "0372888059303"], "unii": ["3L36P16U4R"], "rxcui": ["854868"], "spl_set_id": ["b1a12c83-74ab-febc-e053-2a95a90a1441"], "manufacturer_name": ["Advagen Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-059-30)", "package_ndc": "72888-059-30", "marketing_start_date": "20170601"}, {"sample": false, "description": "90 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-059-90)", "package_ndc": "72888-059-90", "marketing_start_date": "20170601"}], "brand_name": "RABEPRAZOLE SODIUM", "product_id": "72888-059_4844a51a-513a-8b72-e063-6294a90ab996", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Proton Pump Inhibitor [EPC]", "Proton Pump Inhibitors [MoA]"], "product_ndc": "72888-059", "generic_name": "rabeprazole sodium", "labeler_name": "Advagen Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RABEPRAZOLE SODIUM", "active_ingredients": [{"name": "RABEPRAZOLE SODIUM", "strength": "20 mg/1"}], "application_number": "ANDA204237", "marketing_category": "ANDA", "marketing_start_date": "20170601", "listing_expiration_date": "20271231"}